sellModerate cluster of 5
Lampo Craig A sold $21M of APH
SR VP & CFO at AMPHENOL CORP /DE/. 300,000 shares at an average of $71.56, traded Nov 6, 2024, filed Nov 7, 2024.
Warning score
57Value
$21M
300,000 shares
Holdings after
318,116
-49% from before
From 52-week low
-
no price yet
From 52-week high
-
no price yet
Score components
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Rows in this filing
Every transaction in Form 4 0001104659-24-115286, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Nov 6, 2024 | MOption exercise Class A Common Stock | +400,000 | $18.23 | $7.3M | 618,116 | Nov 7, 2024 |
| Nov 6, 2024 | SOpen-market sale Class A Common Stock | -300,000 | $71.56 | $21M | 318,116 | Nov 7, 2024 |
| Nov 6, 2024 | MOption exercise Stock Optionderivative | -400,000 | $0.00 | $0 | 400,000 | Nov 7, 2024 |
Related signals
Other insiders at AMPHENOL CORP /DE/ and this insider’s other filings.
| Score | Side | Company | Insider | Value | Shares | Filed |
|---|---|---|---|---|---|---|
| 65Notable | sell 5 | APH AMPHENOL CORP /DE/ | Straub Peter President, ISS Division | $9.8M | 132,000 | |
| 60Notable | sell 5 | APH AMPHENOL CORP /DE/ | Silverman David M Senior VP, Human Resources | $13M | 180,000 | |
| 60Notable | sell 5 | APH AMPHENOL CORP /DE/ | NORWITT RICHARD ADAM President & CEO | $82M | 1,190,000 | |
| 57Moderate | sell 5 | APH AMPHENOL CORP /DE/ | Lampo Craig A SR VP & CFO | $10M | 150,000 | |
| 50Moderate | sell 5 | APH AMPHENOL CORP /DE/ | D'AMICO LANCE E Sr. VP, Secretary & GenCounsel | $5.2M | 75,000 | |
| 60Notable | sell 5 | APH AMPHENOL CORP /DE/ | Silverman David M Senior VP, Human Resources | $12M | 180,000 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.